Clinical trial

REduction of rIsk for Contrast Induced Nephropathy

NCT01402232

StatusUNKNOWN

Study typeOBSERVATIONAL

Start date2013-01-01

PhaseN/A

Study timeline

Study start (unknown)2013-01-01Date precision: month

Registry last updated2018-08-03

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Contrast Induced Nephropathyunresolved

Interventions

Sponsors & collaborators

Guangdong Provincial People's Hospitallead sponsor

First Affiliated Hospital, Sun Yat-Sen Universitycollaborator

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen Universitycollaborator

Nanfang Hospital, Southern Medical Universitycollaborator

Guangzhou General Hospital of Guangzhou Military Commandcollaborator

Guangdong Medical Collegecollaborator

Dongguan Kanghua Hospitalcollaborator

Dongguan People's Hospitalcollaborator

Maoming People's Hospitalcollaborator

Futian People's Hospitalcollaborator

Longyan City First Hospitalcollaborator

First People's Hospital of Kashgarcollaborator

Mapped research locations

GuangzhouGuangdong, China6

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01402232 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.